Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PVLA | ABCL | URGN | ||
| Company | Palvella Therapeutics Inc | Abcellera Biologics Inc | Urogen Pharma Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 79.73 | 3.19 | 20.57 | ||
| High | 83.47 | 3.21 | 22.21 | ||
| Low | 74.40 | 2.74 | 20.38 | ||
| Latest | 76.43 | 2.78 | 20.52 | ||
| Change | -5.58 | -0.49 | -0.19 | ||
| % Change | -6.80% | -14.98% | -0.92% | ||
| Volume | 286,400 | 11,048,700 | 1,029,000 | ||
| 20-Day Average Volume | 233,915 | 5,229,060 | 785,130 | ||
| Previous Close | 82.01 | 3.27 | 20.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 89.93 | 3.99 | 20.36 | ||
| 20-Day Raw Stochastic | 12.35% | 1.66% | 40.13% | ||
| 20-Day Relative Strength | 40.95 | 31.81 | 47.03 | ||
| Weighted Alpha | +253.41 | -23.96 | +47.46 | ||
| Today's Opinion | 24% Buy | 56% Sell | 24% Buy | ||
| Previous Opinion | 24% Buy | 56% Sell | 24% Buy | ||
| Last Month's Opinion | 64% Buy | 32% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.68% since 01/29/26 | -27.98% since 01/29/26 | -0.82% since 01/29/26 | ||
| Low | 72.22 on 01/30/26 | 2.74 on 02/05/26 | 19.13 on 02/03/26 | ||
| High | 83.47 on 02/05/26 | 3.83 on 01/30/26 | 22.21 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | -13.58% since 01/05/26 | -18.95% since 01/05/26 | -7.28% since 01/05/26 | ||
| Low | 72.22 on 01/30/26 | 2.74 on 02/05/26 | 18.12 on 01/14/26 | ||
| High | 106.27 on 01/15/26 | 4.85 on 01/22/26 | 24.10 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | +0.90% since 11/05/25 | -40.72% since 11/05/25 | +6.27% since 11/05/25 | ||
| Low | 72.22 on 01/30/26 | 2.74 on 02/05/26 | 18.12 on 01/14/26 | ||
| High | 114.69 on 12/22/25 | 4.85 on 01/22/26 | 30.00 on 11/26/25 | ||
| 6-Month | |||||
| %Chg | +103.70% since 08/05/25 | -36.24% since 08/05/25 | -0.97% since 08/05/25 | ||
| Low | 37.33 on 08/07/25 | 2.74 on 02/05/26 | 15.86 on 10/10/25 | ||
| High | 114.69 on 12/22/25 | 6.51 on 10/08/25 | 30.00 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 970,670 | 978,825 | 969,414 | ||
| Shares Outstanding, K | 11,836 | 299,335 | 46,809 | ||
| Annual Sales | 0 | 28,830,000 | 90,400,000 | ||
| Annual Net Income | -17,430,000 | -162,860,000 | -126,870,000 | ||
| Last Quarter Sales | 0 | 8,960,000 | 27,480,000 | ||
| Last Quarter Net Income | -11,350,000 | -57,120,000 | -33,350,000 | ||
| 60-Month Beta | -0.16 | 0.81 | 1.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/11/25 | -0.19 on 11/06/25 | -0.69 on 11/06/25 | ||
| Latest Earnings Date | 03/30/26 | 02/24/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||